Donald G. Payan
2012
In 2012, Donald G. Payan earned a total compensation of $1.9M as Executive Vice President, President of Discovery and Research at Rigel Pharmaceuticals, a 64% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $256,808 |
|---|---|
| Option Awards | $1,102,840 |
| Salary | $540,648 |
| Other | $5,148 |
| Total | $1,905,444 |
Payan received $1.1M in option awards, accounting for 58% of the total pay in 2012.
Payan also received $256.8K in non-equity incentive plan, $540.6K in salary and $5.1K in other compensation.
Rankings
In 2012, Donald G. Payan's compensation ranked 3,731st out of 11,487 executives tracked by ExecPay. In other words, Payan earned more than 67.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,731 out of 11,487 | 68th |
Division Manufacturing | 1,291 out of 4,253 | 70th |
Major group Chemicals And Allied Products | 290 out of 1,203 | 76th |
Industry group Drugs | 169 out of 925 | 82nd |
Industry Pharmaceutical Preparations | 132 out of 700 | 81st |
Source: SEC filing on March 30, 2015.
Payan's colleagues
We found four more compensation records of executives who worked with Donald G. Payan at Rigel Pharmaceuticals in 2012.